• DISCOVER: A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex with Men and Are At Risk of HIV-1 Infection (GS-US-412-2055)
• HIPvac: Randomised controlled trial of Imiquimod cream vs. podophyllotoxin in combination with quadrivalent HPV or control vaccination in the treatment and prevention of recurrence of anogenital warts
• HIV BioResorce
• HPV Sampling Study
• NATSAL: The National Survey of Sexual Attitudes and Lifestyles
• NIHR HPRU: Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections
• Partners of people on ART - a New Evaluation of the Risks (The PARTNER study)
• Pilot of enhanced LGV surveillance in Europe
• PrEP IMPACT Trial: A pragmatic health technology assessment of PrEP and implementation
• T-pal-Omics Study: Syphilis Transcriptomics: Proof of concept study that aims to utilise next generation sequencing and transcriptomic approaches to understand infection with Treponema pallidum